Patent details
EP1667992 Title: QUINAZOLINE DERIVATIVES
Basic Information
- Publication number:
- EP1667992
- PCT Application Number:
- PCT/GB/2004/003937
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP047684832
- PCT Publication Number:
- WO/2005/028469
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- QUINAZOLINE DERIVATIVES
- French Title of Invention:
- DERIVES DE QUINAZOLINE
- German Title of Invention:
- CHINAZOLINDERIVATE
- SPC Number:
Dates
- Filing date:
- 15/09/2004
- Grant date:
- 24/01/2007
- EP Publication Date:
- 24/01/2007
- PCT Publication Date:
- 31/03/2005
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/06/2006
- EP B1 Publication Date:
- 24/01/2007
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/09/2019
- Expiration date:
- 15/09/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/09/2004
- Name:
- AstraZeneca AB
- Address:
- Sodertalje, 151 85, Sweden (SE)
Agent
- Name:
- VAN MALDEREN MICHEL
- From:
- 12/04/2007
- Address:
- ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- BARLAAM Bernard Christophe, AstraZeneca Pharma
- Address:
- France (FR)
2
- Name:
- BRADBURY Robert Hugh AstraZeneca R & D Alderley
- Address:
- United Kingdom (GB)
3
- Name:
- HENNEQUIN Laurent Francois Andre
- Address:
- France (FR)
Priority
1
- Priority Number:
- 03292309
- Priority Date:
- 19/09/2003
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 04291248
- Priority Date:
- 14/05/2004
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- C07D 401/12;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 24/08/2018
- Last Annual Fee Paid Number:
- 15
- Last Annual Fee Paid Amount:
- 213 Euro
- Payer:
- MARKS & CLERK LLP
| Filing date | Document type | Number of pages |
|---|